Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Rush Street Interactive Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Rush Street Interactive Inc trades at $18.9 (market cap $2.35B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 5.4× Rush Street Interactive Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Rush Street Interactive Inc for 13 Days on average.
| HALO | RSI | |
|---|---|---|
Market Cap | $12.58B | $2.35B |
Volume | 2,179,278 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $34.52 |
52-Week Low | $61.63 | $15.89 |
Typical Hold Time | 1 Days | 13 Days |
Enterprise Value | $14.49B | $2.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RSI (Rush Street Interactive) trades at $18.90, down 6.62% recently, with a bearish technical signal from moving averages. The company shows strong revenue growth from $1.13B in 2025 to $1.4B in 2026, though net income margin compressed to 2.33%. Recent Q2 2026 earnings beat expectations with EPS of $0.15 versus $0.1499 expected. Analyst consensus remains strongly bullish with 10 buy ratings and a $34.88 price target, representing 85% upside potential from current levels.
The stock presents significant upside based on analyst targets but faces execution risks amid competitive online gaming markets. High P/E ratio of 65.55 suggests premium valuation requiring sustained growth. Institutional interest remains strong with BlackRock's $448M investment in Q2 2026. Near-term performance hinges on Q3 earnings delivery and sports betting market expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
